You are here:
NICE
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia
Technology appraisal guidance
Reference number:
TA119
Published:
28 February 2007
Guidance
Tools and resources
Information for the public
Evidence
History
Research recommendations coming out of this guidance
There are no research recommendations for TA119